E-LIB Suche - Ergebnisse für: Muñoz‐Couselo, E.

1

Efficacy and safety of cemiplimab in the treatment of advan..:

Cañueto, J. ; Muñoz‐Couselo, E. ; Cardona‐Machado, C....
Journal of the European Academy of Dermatology and Venereology. , 2024

Link: https://doi.org/10.1111/..

2

Immune checkpoint blockers in solid organ transplant recipi..:

Remon, J. ; Auclin, E. ; Zubiri, L....
ESMO Open. 9 (2024) 5 - p. 103004 , 2024

Link: https://doi.org/10.1016/..

3

Non-invasive biomarkers for response and survival predictio..:

Bernatowicz, K. ; Vieito, M. ; Berche, R....
European Journal of Cancer. 174 (2022) - p. S70 , 2022

Link: https://doi.org/10.1016/..

4

Corrigendum to 'Pembrolizumab for locally advanced and recu..:

Hughes, B.G.M. ; Munoz-Couselo, E. ; Mortier, L....
Annals of Oncology. 33 (2022) 8 - p. 853 , 2022

Link: https://doi.org/10.1016/..

5

Peripheral blood neutrophil/lymphocyte ratio as a prognosti..:

Mendes, A.S. ; Muñoz-Couselo, E. ; Simões, J....
European Journal of Cancer. 175 (2022) - p. S32 , 2022

Link: https://doi.org/10.1016/..

6

Pembrolizumab for locally advanced and recurrent/metastatic..:

Hughes, B.G.M. ; Munoz-Couselo, E. ; Mortier, L....
Annals of Oncology. 32 (2021) 10 - p. 1276-1285 , 2021

Link: https://doi.org/10.1016/..

7

SEOM clinical guideline for the management of cutaneous mel..:

Majem, M. ; Manzano, J. L. ; Marquez-Rodas, I....
Clinical and Translational Oncology. 23 (2021) 5 - p. 948-960 , 2021

Link: https://doi.org/10.1007/..

8

SEOM clinical guideline for the management of immune-relate..:

Majem, M. ; García-Martínez, E. ; Martinez, M....
Clinical and Translational Oncology. 22 (2020) 2 - p. 213-222 , 2020

Link: https://doi.org/10.1007/..

9

Dynamics of clinical biomarkers as predictors of immunother..:

Hernando-Calvo, A. ; García-Alvarez, A. ; Villacampa, G....
Clinical and Translational Oncology. 23 (2020) 2 - p. 311-317 , 2020

Link: https://doi.org/10.1007/..

10

A retrospective, multicenter study of the efficacy of lapat..:

Gavilá, J. ; De La Haba, J. ; Bermejo, B....
Clinical and Translational Oncology. 22 (2019) 3 - p. 420-428 , 2019

Link: https://doi.org/10.1007/..

11

Targeting FGFR pathway in breast cancer:

Perez-Garcia, J. ; Muñoz-Couselo, E. ; Soberino, J...
The Breast. 37 (2018) - p. 126-133 , 2018

Link: https://doi.org/10.1016/..

12

SEOM clinical guideline for the management of immune-relate..:

Majem, M ; García-Martínez, E ; Martinez, M...
Clinical and Translational Oncology, 22 (2), 213-222.. , 2023

Link: https://idus.us.es/handl..

13

SEOM clinical guideline for the management of cutaneous mel..:

Majem, M ; Manzano, J. L ; Marquez-Rodas, I...
Clinical and Translational Oncology, 23 (5), 948-960.. , 2022

Link: https://idus.us.es/handl..

14

SEOM clinical guideline for the management of cutaneous mel..:

Majem, M ; Manzano, J L ; Marquez-Rodas, I...
http://hdl.handle.net/10668/17259. , 2021

Link: http://hdl.handle.net/10..

15

Durable Response to Vemurafenib and Cobimetinib for the Tre..:

Álamo MC ; Ochenduszko S ; Crespo G...
https://www.dovepress.com/durable-response-to-vemurafenib-and-cobimetinib-for-the-treatment-of-b-peer-reviewed-fulltext-article-OTT. , 2021

Link: https://doaj.org/article..